Monosacáridos

Glycolytic inhibitor; pro-apoptotic; anti-cancer agent

Methyl 2,3-di-O-acetyl-4,6-O-(4-methoxybenzylidene)-a-D-mannopyranoside is a custom synthesis that contains a fluorinated sugar with a methyl group attached to the 4 position. The oligosaccharide is synthesized through click chemistry and has been modified with an acetate at the 6 position. The CAS number is 108739-53-0. The carbohydrate is a complex carbohydrate that can be found in nature or synthesized in the laboratory.

1,2:3,4-Di-O-isopropylidene-a-D-galactopyranose, also known as diacetone-D-galactose and galactose diacetonide, is a partially protected monosaccharide building block with isopropylidene groups on the 1,2 and 3,4 hydroxyls. The 6-hydroxyl is unprotected and able to undergo a variety of chemical transformations, such as glycosylation acting as a glycosyl acceptor to form 1,6-linked disaccharides.

2-Iodoethyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside is a high purity custom synthesis that can be modified with Click chemistry. It can be synthesized by modification of methylated glycosides and saccharides. This product has been shown to have a wide range of applications in the areas of fluorination, glycosylation, and methylation. The sugar moiety is an oligosaccharide made up of one or more monosaccharides (simple sugars) joined together by glycosidic bonds. This product is often found in complex carbohydrates such as glycogen and starch.

2’-(N-Hexadecanoylamino)-4’-nitrophenyl-b-D-galactopyranoside is a synthetic substrate that is used to diagnose and monitor brain diseases. It can be used in the diagnosis of Alzheimer's disease by measuring the amount of amniotic fluid that leaks into the brain. The rate of hydrolysis of this substrate has been shown to be higher in patients with Alzheimer's disease than in healthy controls. This synthetic substrate is also useful for monitoring the activity of taurocholate galactohydrolase, which is an enzyme that breaks down bile salts and plays a role in cholesterol metabolism. The rate of hydrolysis has been found to be increased in patients with Parkinson's disease, but not in those with Alzheimer's disease or healthy controls. 2’-(N-Hexadecanoylamino)-4’-nitrophenyl-b-D-galactop

Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.

N-[2-(4'-Methoxyphenylacetonitrile)]-2,3,4,6-tetra-O-pivaloyl-D-glucopyranoside is a custom synthesis of a carbohydrate. It is a synthetic saccharide that is modified by fluorination and methylation. This compound has high purity and can be custom synthesized to order.

1,3,5-Tri-O-benzoyl-a-L-ribofuranose is a synthetic sugar with a complex carbohydrate structure. It is synthesized by the sequential addition of benzoyl groups to the alditol acetal of ribose. The molecular weight of this compound is 598.6 g/mol and its CAS number is 171866-30-1. 1,3,5-Tri-O-benzoyl-a-L-ribofuranose has been shown to be an excellent substrate for glycosylation and methylation reactions due to the presence of three reactive hydroxyl groups that can react with nucleophiles such as amines or thiols. Methylation reactions are typically carried out in the presence of sodium methoxide in methanol at room temperature for several hours. Glycosylation reactions require the use of activated glycosyl donors such as UDP glucose, UDP galactose

3,4-O-Isopropylidene-L-arabinose (3,4-OIRA) is an isopropylidene derivative of L-arabinose. 3,4-OIRA has been shown to be a substrate for glycosylation reactions with various other sugars. It can also undergo methylation reactions and has been modified by fluorination. 3,4-OIRA is a food additive that belongs to the category of complex carbohydrates.